dual enkephalin-degrading enzyme inhibitors (Sanofi-Synthelabo/INSERM)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namedual enkephalin-degrading enzyme inhibitors (Sanofi-Synthelabo/INSERM)
Drug Alias Nameenkephalinases (Sanofi-Synthelabo/INSERM)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAminopeptidase inhibitorsEndopeptidases inhibitors
TargetsEndopeptidasesAminopeptidase
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi-Synthelabo
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInsermSanofi-Synthelabo
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A